15
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7766 | Remdesivir | GS-5734 | SARS-CoV , DNA/RNA Synthesis |
Remdesivir (GS-5734) is a nucleoside analog, a broad-spectrum antiviral compound that exerts its activity by inhibiting the RNA-dependent RNA polymerase of viruses. Remdesivir is active against Ebola, SARS, and MERS viru... | |||
T39334 | Remdesivir nucleoside monophosphate | ||
Remdesivir nucleoside monophosphate, a metabolite of Remdesivir, is a potent antiviral compound with nucleoside analogue characteristics. It exhibits effective antiviral activity against both SARS-CoV and MERS-CoV. | |||
T69731 | Remdesivir maleate | ||
Remdesivir, also known as GS-5734, is a prodrug form of the antiviral nucleoside analog GS-44152. Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit SARS-CoV-2, in vitro and in vivo. Efficacy of re... | |||
T12702 | Remdesivir-D5 | GS-5734-D5 | Others |
Remdesivir-D5 is a deuterium labeled Remdesivir. Remdesivir is a nucleoside analogue, with effective antiviral activity. | |||
T38577 | Remdesivir O-desphosphate acetonide impurity | ||
Remdesivir O-desphosphate acetonide impurity is a contaminant found in Remdesivir. Remdesivir (GS-5734) is a nucleoside analogue known for its potent antiviral properties, particularly in inhibiting SARS-CoV-2 (COVID-19)... | |||
T74467 | Remdesivir de(ethylbutyl 2-aminopropanoate) | ||
Remdesivir de(ethylbutyl 2-aminopropanoate) is a recognized impurity in Remdesivir, a nucleoside analog demonstrating potent antiviral efficacy. It exhibits EC50 values of 74 nM against SARS-CoV and MERS-CoV in human air... | |||
T39335 | Anti-virus agent 1 | Anti-virus agent 1,Remdesivir isopropyl ester analog | |
Anti-virus agent 1 (compound 4i), a phosphoramidate prodrug of GS-5734, exhibits potent antiviral efficacy. It is primarily utilized in the study of coronavirus and Ebola virus (EBOV). | |||
T4686 | Simeprevir | TMC435,TMC-435350,Olysio | HCV Protease , SARS-CoV |
Simeprevir (TMC435) is a potent HCV NS3/4A protease inhibitor, and inhibits HCV replication with EC50 of 8 nM. | |||
T69656 | E197 | ||
E197 is a DOCK5 inhibitor. E197 can inhibit both mouse and human osteoclast activity. In particular, E197 prevented pathological bone loss in mice. Most interestingly, treatment with E197 did not affect osteoclast and os... | |||
T5539 | GS-443902 | Nucleoside Antimetabolite/Analog , HCV Protease , SARS-CoV , DNA/RNA Synthesis , RSV , Drug Metabolite | |
GS-441524 was shown to be a safe and effective treatment for feline infectious peritonitis (FIP). The optimum dosage was found to be 4.0 mg/kg SC q24h for at least 12 weeks | |||
T7222 | GS-441524 | GS 441524 triphosphate | Others , SARS-CoV , DNA/RNA Synthesis |
GS-441524 treatment of cats with naturally occurring feline infectious peritonitis. | |||
T37959 | GS-704277 | ||
GS-704277, an alanine metabolite derived from Remdesivir, a nucleoside analogue acknowledged for its potent antiviral efficacy, demonstrates remarkable effectiveness in vitro for the management of SARS-CoV-2 (COVID-19) i... | |||
T36440 | GS-441524 tris-isobutyryl ester | ||
GS-441524tris-isobutyryl ester is a prodrug form of the antiviral nucleoside analog and remdesivir metabolite GS-441524 .1It reduces the cytopathic effect of respiratory syncytial virus (RSV) in infected HEp-2 cells with... | |||
T38761 | GS-443902 trisodium | GS-441524triphosphatetrisodium,Remdesivirmetabolitetrisodium | |
GS-443902 trisodium (GS-441524 triphosphate trisodium), the active triphosphate metabolite of Remdesivir (GS-5734), serves as a potent inhibitor of viral RNA-dependent RNA-polymerases (RdRp), displaying inhibitory concen... | |||
T69657 | GS-441524 HCl | ||
GS-441524 is a potent inhibitor of feline infectious peritonitis (FIP) virus with an EC50 of 0.78 μM.. GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infecti... |
Cat No. | Product Name | ||
---|---|---|---|
L1710 | Anti-COVID-19 Compound Library | 1160 compounds | |
A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; |